TP53 and primary effusion lymphoma: Nutlin-3a, a small molecule inhibitor of the p53/MDM2 interaction, which promotes p53 reactivation, kills PEL cells in culture and has potent anti-tumor activity in mice bearing PEL tumors [97,98].